INDICATOR | Year | El Salvador | Venezuela | Bolivia | Mean |
---|---|---|---|---|---|
Number of first-line ART regimens in use | 2012 | 11 | 14 | 9 | 11 |
2013 | 12 | 4 | 6 | 7 | |
Percentage of patients in the preferred first-line ART regimens recommended by WHO (TDF + 3TC (or FTC) + EFV) | 2012 | 85 % | 39 % | 98 % | 74 % |
2013 | 92 % | 43 % | 99 % | 78 % | |
Percentage of patients in the preferred first-line ART regimens recommended by WHO (TDF + 3TC [or FTC] + EFV) | 2012 | 9 % | 63 % | 37 % | 36 % |
2013 | 20 % | 43 % | 66 % | 43 % | |
Percentage of patients in first-line ART regimens including obsolete antiretrovirals (ddl, d4T, IDV, NFV) | 2012 | 13 % | 0 % | 1 % | 5 % |
2013 | 2 % | 0 % | 0 % | 1 % | |
Number of second-line ART regimens in use | 2012 | 8 % | 18 % | 8 % | 11 % |
2013 | 10 % | 4 % | 7 % | 7 % | |
Percentage of patients in second-line ART regimens recommended by WHO | 2012 | 55 % | 0 % | 74 % | 43 % |
2013 | 64 % | 50 % | 83 % | 65 % | |
Percentage of patients in second-line ART regimens including obsolete ARVs | 2012 | 35 % | 1 % | 19 % | 18 % |
2013 | 20 % | 0 % | 8 % | 9 % |